To test this hypothesis, FGF9-OE and littermate control mice were continuously administered DOX beginning 3 days prior to infection (d-3), infected intranasally (i.n.)(d0) with IAV A/WSN/33 (WSN), and then monitored for weight loss and survival. Here, FGF9 is linked to infection.